Semaglutide: FDA-approved for weight management (2021) and type 2 diabetes Widely available via prescription Available from research peptide suppliers Established insurance coverage pathways Years of post-marketing safety data Cagrilintide: Not FDA-approved (investigational as of March 2026) Phase 3 REDEFINE trials complete with positive results Available from some research peptide suppliers as a research chemical No insurance coverage Limited long-term safety data (68 weeks maximum from trials) Cost Considerations Without FDA approval, cagrilintide has no established retail price
J Physiol Pharmacol 64:597612 Leeuwin RS, Vanderwal JK, Spanjer W (1984) Interactions of cholinesterase inhibitors and glucocorticoids with ketamine and pentobarbitone-induced general anesthesia in the rat: possible effects on central cholinergic activity
It gives the molecule redox activity, meaning AHK-Cu can take part in oxidative and enzymatic processes linked to cellular stress and repair
[DOI] [PMC free article] [PubMed] [Google Scholar] 170.Braley T.J., Chervin R.D
Beyond its direct effects on structural proteins, GHK-Cu provides significant antioxidant protection
A 30 mL vial of bacteriostatic water costs a few dollars